What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Disease
- Surgery
His scientific interests lie mostly in Epilepsy, Anesthesia, Status epilepticus, Pediatrics and Adverse effect.
His Epilepsy study integrates concerns from other disciplines, such as Surgery and Electroencephalography.
The study incorporates disciplines such as Tolerability, Valproic Acid, Phenytoin and Pharmacotherapy in addition to Anesthesia.
His Status epilepticus research focuses on Levetiracetam and how it connects with Lorazepam and Clinical trial.
His Pediatrics study deals with Encephalopathy intersecting with Cerebrospinal fluid and Pathology.
His Adverse effect study combines topics from a wide range of disciplines, such as Odds ratio, Standard treatment and Adjunctive treatment.
His most cited work include:
- A Definition and Classification of Status epilepticus--Report of the ILAE Task Force on Classification of Status Epilepticus (866 citations)
- The consequences of refractory epilepsy and its treatment (277 citations)
- Unified EEG terminology and criteria for nonconvulsive status epilepticus. (265 citations)
What are the main themes of his work throughout his whole career to date?
Eugen Trinka mainly focuses on Epilepsy, Anesthesia, Status epilepticus, Pediatrics and Neuroscience.
His Epilepsy research is multidisciplinary, incorporating perspectives in Internal medicine and Electroencephalography.
Eugen Trinka focuses mostly in the field of Electroencephalography, narrowing it down to topics relating to Audiology and, in certain cases, Cognition.
Eugen Trinka interconnects Randomized controlled trial and Phenytoin in the investigation of issues within Anesthesia.
His Status epilepticus research incorporates elements of Levetiracetam, Intensive care medicine, Refractory and Etiology.
His study in Pediatrics is interdisciplinary in nature, drawing from both Neurology, Incidence and Retrospective cohort study.
He most often published in these fields:
- Epilepsy (44.11%)
- Anesthesia (19.54%)
- Status epilepticus (19.97%)
What were the highlights of his more recent work (between 2017-2021)?
- Epilepsy (44.11%)
- Status epilepticus (19.97%)
- Internal medicine (16.67%)
In recent papers he was focusing on the following fields of study:
His primary scientific interests are in Epilepsy, Status epilepticus, Internal medicine, Electroencephalography and Pediatrics.
Epilepsy is closely attributed to Tolerability in his research.
His Status epilepticus research also works with subjects such as
- Refractory which is related to area like Anesthesia,
- Etiology that connect with fields like Semiology,
- Neurology which intersects with area such as Cognition.
His Internal medicine research is multidisciplinary, incorporating elements of Placebo and Eslicarbazepine acetate.
His work deals with themes such as Radiology, Audiology and Scalp, which intersect with Electroencephalography.
Eugen Trinka combines subjects such as Benzodiazepine, Incidence, Young adult, Confidence interval and Single Center with his study of Pediatrics.
Between 2017 and 2021, his most popular works were:
- Proposed consensus definitions for new-onset refractory status epilepticus (NORSE), febrile infection-related epilepsy syndrome (FIRES), and related conditions. (113 citations)
- Neutrophil-to-Lymphocyte Ratio in Acute Cerebral Hemorrhage: a System Review. (86 citations)
- Efficacy and Safety of Cannabidiol in Epilepsy: A Systematic Review and Meta-Analysis (70 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Disease
- Surgery
Eugen Trinka mainly investigates Epilepsy, Internal medicine, Status epilepticus, Adverse effect and Electroencephalography.
His research in Epilepsy intersects with topics in Tolerability and Randomized controlled trial.
The Status epilepticus study combines topics in areas such as Case fatality rate, Pediatrics, Refractory and Etiology.
His Refractory research is multidisciplinary, relying on both Intravenous ketamine, Anesthesia, Neurointensive care and Prospective cohort study.
His Adverse effect research integrates issues from Brivaracetam and Adjunctive treatment.
Eugen Trinka has included themes like Temporal lobe and Physical medicine and rehabilitation in his Electroencephalography study.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
